Development of an Oral Subunit Vaccine to Protect Rainbow Trout Against Infectious Hematopoietic Necrosis Virus (IHNV)

Abstract Infectious hematopoietic necrosis virus (IHNV) is a highly virulent pathogen of salmonids that causes severe mortality in aquaculture, particularly during early developmental stages. Current vaccination strategies rely mainly on injectable DNA vaccines, which are labour-intensive and unsuitable for large-scale immunization of juvenile fish. In this study, we developed and evaluated two recombinant nanostructured subunit vaccines based on the IHNV glycoprotein: IHNV NP and IHNV-IFN NP , the latter incorporating interferon-gamma (IFNγ) as an immunomodulatory adjuvant. Both vaccines were produced in Escherichia coli as nanoparticles. In vitro assays using the rainbow trout macrophage-like cell line RTS11 showed efficient cellular uptake of both subunit vaccines and colocalization of IHNV-IFN NP within acidic lysosomes, where antigen processing takes place. Gene expression analysis in RTS11 revealed that the IFNγ-adjuvanted vaccine significantly upregulated antiviral and immune-related genes associated with innate and adaptive responses, including vig1 , ip10 , mx , ccl4 , il-1β , mhcI , and mhcII , compared with the non-adjuvanted formulation. Furthermore, an in vivo trial demonstrated that oral administration by intubation of IHNV-IFN NP induced partial protective responses against IHNV challenge in rainbow trout fingerlings. In addition, ELISA and hindgut gene expression analysis in juvenile rainbow trout following oral intubation with IHNV-IFN NP provided further evidence of the vaccine’s potential to induce mucosal immune responses. These findings indicate that an IFNγ-functionalized nanostructured subunit vaccine enhances immune activity against IHNV and represent a promising strategy for the development of practical, modular antiviral oral vaccines in aquaculture.

Authors

Institutions

Publication Details

Journal
Marine Biotechnology
Published
2026-11-12
DOI
https://doi.org/10.1007/s10126-026-10728-w
Primary Topic
Aquaculture disease management and microbiota
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of an Oral Subunit Vaccine to Protect Rainbow Trout Against Infectious Hematopoietic Necrosis Virus (IHNV)

María del Mar Ortega-Villaizán, Mauricio Rojas-Peña, Borja Ordóñez-Grande, Ainhoa Gómez-Quintanilla et al.
Marine Biotechnology
Aquaculture disease management and microbiota
article

Development of an Oral Subunit Vaccine to Protect Rainbow Trout Against Infectious Hematopoietic Necrosis Virus (IHNV)

María del Mar Ortega-Villaizán, Mauricio Rojas-Peña, Borja Ordóñez-Grande, Ainhoa Gómez-Quintanilla, Luis Pérez, Marlid Garcia-Ordoñez, Oluwabusayo Israe Okeleye, Nerea Roher, Patricia Aceituno, Hamza Hassine
article en

Abstract

Abstract Infectious hematopoietic necrosis virus (IHNV) is a highly virulent pathogen of salmonids that causes severe mortality in aquaculture, particularly during early developmental stages. Current vaccination strategies rely mainly on injectable DNA vaccines, which are labour-intensive and unsuitable for large-scale immunization of juvenile fish. In this study, we developed and evaluated two recombinant nanostructured subunit vaccines based on the IHNV glycoprotein: IHNV NP and IHNV-IFN NP , the latter incorporating interferon-gamma (IFNγ) as an immunomodulatory adjuvant. Both vaccines were produced in Escherichia coli as nanoparticles. In vitro assays using the rainbow trout macrophage-like cell line RTS11 showed efficient cellular uptake of both subunit vaccines and colocalization of IHNV-IFN NP within acidic lysosomes, where antigen processing takes place. Gene expression analysis in RTS11 revealed that the IFNγ-adjuvanted vaccine significantly upregulated antiviral and immune-related genes associated with innate and adaptive responses, including vig1 , ip10 , mx , ccl4 , il-1β , mhcI , and mhcII , compared with the non-adjuvanted formulation. Furthermore, an in vivo trial demonstrated that oral administration by intubation of IHNV-IFN NP induced partial protective responses against IHNV challenge in rainbow trout fingerlings. In addition, ELISA and hindgut gene expression analysis in juvenile rainbow trout following oral intubation with IHNV-IFN NP provided further evidence of the vaccine’s potential to induce mucosal immune responses. These findings indicate that an IFNγ-functionalized nanostructured subunit vaccine enhances immune activity against IHNV and represent a promising strategy for the development of practical, modular antiviral oral vaccines in aquaculture.

Marine BiotechnologyVol. 28(6)
Universitat de Miguel Hernández d'Elx (ES), Universitat Autònoma de Barcelona (ES), Roslin Institute (GB), Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES), Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE) (ES), University of Edinburgh (GB)
Universitat Autònoma de Barcelona
Good health and well-being
Aquaculture disease management and microbiota
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon